Integrin α6/Akt/Erk signaling is essential for human breast cancer resistance to radiotherapy

DNA damage-induced cell death: From specific DNA lesions to the DNA damage response and apoptosis

(2012) Wynand P. Roos et al.   CANCER LETTERS

The RAS/RAF/MEK/ERK and the PI3K/AKT signalling pathways: role in cancer pathogenesis and implications for therapeutic approaches

(2012) Antonella De Luca et al.   EXPERT OPINION ON THERAPEUTIC TARGETS

Breast cancer stem-like cells show dominant homologous recombination due to a larger S-G2fraction

(2011) Osama Al-Assar et al.   CANCER BIOLOGY & THERAPY

CD49f-based selection of circulating tumor cells (CTCs) improves detection across breast cancer subtypes

(2011) Bianca Mostert et al.   CANCER LETTERS

Inhibition of telomerase activity by HDV ribozyme in cancers

(2011) Yingying Lu et al.   JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH

CD49f and CD61 identify Her2/neu-induced mammary tumor-initiating cells that are potentially derived from luminal progenitors and maintained by the integrin–TGFβ signaling

(2011) P-K Lo et al.   ONCOGENE

Curcumin Inhibition of Integrin ( 6 4)-Dependent Breast Cancer Cell Motility and Invasion

(2008) H. I. Kim et al.   Cancer Prevention Research